niacinamide has been researched along with motesanib diphosphate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gosselin, NH; Hsu, CP; Lu, JF; Mouksassi, MS | 1 |
| Benson, A; Deming, D; Engstrom, P; Feng, Y; Giang, GY; Hinshaw, JL; Klein, L; Lubner, S; Meropol, N; Mulcahy, M; O'Dwyer, P; Payne, J; Stella, P; Teitelbaum, U | 1 |
| Chen, L; Chen, SJ; Chen, SY; Guo, LY; Jiang, M; Li, XY; Luo, B; Lv, YX; Pan, YM; Tang, H; Tang, JM; Wang, JN; Wang, L; Yan, YW; Yang, JY; Zhang, L; Zhang, YE; Zheng, F; Zhong, S | 1 |
| Al-Salahi, R; El-Nahhas, T; Ezzeldin, E; Iqbal, M | 1 |
| Byun, SS; Ho, JN; Lee, S; Lee, SE; Youn, JI | 1 |
5 other study(ies) available for niacinamide and motesanib diphosphate
| Article | Year |
|---|---|
Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients.
Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Asian People; Biotransformation; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Indoles; Male; Middle Aged; Models, Biological; Neoplasms; Niacinamide; Protein Binding; Protein Kinase Inhibitors; Serum Albumin, Human | 2015 |
E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Humans; Indoles; Middle Aged; Neuroendocrine Tumors; Niacinamide; Octreotide; Treatment Outcome | 2018 |
VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cell Movement; Cell Proliferation; Indoles; Male; Microvessels; Muscle, Smooth, Vascular; Myocardial Infarction; Myocardium; Niacinamide; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; RNA Interference; RNA, Small Interfering; Vagus Nerve Stimulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B | 2018 |
Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Indoles; Limit of Detection; Liquid-Liquid Extraction; Male; Niacinamide; Protein Kinase Inhibitors; Rats, Wistar; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Indoles; Niacinamide; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; S Phase Cell Cycle Checkpoints; Signal Transduction; Urinary Bladder Neoplasms | 2019 |